Pulmonary Amyloidosis: Diverse Clinical and Histopathological Manifestations - A Series of Five Cases

Authors

  • Richa Bhartiya Department of Pathology, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India
  • Pallavi Mehra Department of Pathology and Laboratory Medicine, Patna Medical College, Patna, India
  • Vishal Tayade Department of Pathology, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India
  • Navin K. Bariar Department of Pathology, Patna Medical College, Patna, India
  • Mansi Karwa Department of Pathology, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India
  • Pritisha Choudhury Department of Pathology, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India

DOI:

https://doi.org/10.21276/apalm.3683

Keywords:

pulmonary amyloidosis, localized amyloidosis, systemic amyloidosis, congo red staining, immunohistochemistry, lung pathology, case series, amyloid subtyping

Abstract

Pulmonary amyloidosis, a rare condition caused by the abnormal deposition of protein fibrils, most often the AL (light chain) type, within the lung, frequently presents a diagnostic challenge. Its clinical manifestations often resemble more prevalent lung diseases like cancer or infections. A crucial step is to differentiate between disease limited to the respiratory system and widespread systemic involvement, as this guides the appropriate treatment. This report provides a retrospective analysis of five histologically confirmed cases of pulmonary amyloidosis, detailing their presenting clinical features, radiological findings, microscopic tissue characteristics, immunohistochemical analysis, and results from systemic evaluations. Our patient group, comprising three males and two females aged between 38 and 67 years, presented with varied initial symptoms: three had lung masses, one exhibited pleural effusion with concurrent liver disease, and another was being treated for tuberculosis. Microscopic examination revealed discrete amyloid nodules in three cases, diffuse interstitial deposition in one, and a pleural based accumulation in another. Immunohistochemical studies confirmed AL-type amyloid in three cases, AA-type in one, while the specific amyloid type remained undetermined in a fifth case. A confirmed diagnosis of systemic amyloidosis was made in only one patient. In one instance, nodular pulmonary amyloidosis occurred alongside fungal colonization. Pulmonary amyloidosis often poses a diagnostic conundrum in lung pathology. While localized nodular forms generally follow a benign clinical course, diffuse patterns necessitate a thorough systemic evaluation, even when serological indicators are negative. Advanced techniques like mass spectrometry and extensive imaging are becoming more vital for accurate subtyping and informed treatment decisions.

References

1. Gandham AK, Gayathri AR, Sundararajan L. Pulmonary amyloidosis: A case series. Lung India. 2019 May–Jun;36(3):229–232.

2. Moy LN, Mirza M, Moskal B, Asado N, Shah B, Bitran J, et al. Pulmonary AL amyloidosis: A review and update on treatment options. Ann Med Surg (Lond). 2022 Aug;80:104060.

3. Milani P, Basset M, Russo F, Foli A, Palladini G, Merlini G. The lung in amyloidosis. Eur Respir Rev. 2017 Sep 6;26(145):170046.

4. Wadhera S, Swain RN, Jandial A, Sachdeva MU, Nada R, Malhotra P, et al. Diffuse alveolar-septal amyloidosis and paravertebral amyloidoma presenting as exertional desaturation. Indian J Hematol Blood Transfus. 2025 May 17.

5. Neacşu F, Vârban AŞ, Simion G, Şurghie R, Pătraşcu OM, Sajin M, et al. Lung cancer mimickers – a case series of seven patients and review of the literature. Rom J Morphol Embryol. 2021 Jul–Sep;62(3):697–704.

6. Riehani A, Soubani AO. The spectrum of pulmonary amyloidosis. Respir Med. 2023 Nov;218:107407.

7. Kratka K, Sistik P, Olivkova I, Kusnierova P, Svagera Z, Stejskal D. Mass spectrometry-based proteomics in clinical diagnosis of amyloidosis and multiple myeloma: A review (2012–2024). J Mass Spectrom. 2025 Mar;60(3):e5116.

8. Fisher B, Ikeji C, Brackney C, Dhupar R. Pulmonary amyloidosis presenting as recurrent pleural effusion and hemoptysis leading to pulmonary infarction and fatal cardiopulmonary arrest: a case report. Arch Surg Surg Educ. 2022;4:043.

9. Li F, Li J, Li Y, Shang D, Hou X, He Y, Li G. Imaging and clinical features of nodular pulmonary amyloidosis. J Thorac Imaging. 2025 Sep 1;40(5):e0830.

10. Chakraborty R, Bellofiore C, Basset M, Nuvolone M, Foli A, Merlini G, et al. PB2151: Clinical features and outcomes of diffuse pulmonary light chain amyloidosis: a rare presentation of systemic AL amyloidosis. HemaSphere. 2023 Aug 8;7(S3):e740260a.

11. Klotz SA, Sobonya RE, Lipke PN, Garcia-Sherman MC. Serum amyloid P component and systemic fungal infection: does it protect the host or is it a Trojan horse? Open Forum Infect Dis. 2016 Aug 3;3(3):ofw166.

12. Janssens I, Lambrecht BN, Van Braeckel E. Aspergillus and the lung. Semin Respir Crit Care Med. 2024 Feb;45(1):3–20.

Downloads

Published

05-01-2026

Issue

Section

Case Report / Case Series

How to Cite

1.
Pulmonary Amyloidosis: Diverse Clinical and Histopathological Manifestations - A Series of Five Cases. Ann of Pathol and Lab Med [Internet]. 2026 Jan. 5 [cited 2026 Jan. 7];13(1):C52-C57. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3683